VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
暂无分享，去创建一个
I. Wistuba | J. Wargo | P. Sharma | P. Troncoso | Jianjun Gao | J. Blando | Hao Zhao | J. Allison | C. Logothetis | C. Pettaway | E. Efstathiou | J. Ward | L. Z. Shi | Manuel A. Sepulveda | S. Subudhi | L. Vence | Hong Chen | Jianfeng Chen | J. Sun | L. Shi | Padmanee Sharma